ArticleMedicine2026
Riedel thyroiditis secondary to papillary thyroid carcinoma: A case report.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
rationaleRiedel thyroiditis (RT) is categorized as an immunoglobulin G4-related disease (IgG4-RD), a condition that is seldom encountered in clinical practice. IgG4-RDs have been linked to an elevated risk of malignancy. Although prior studies have documented instances where IgG4-RDs were induced by malignant tumors, such occurrences are still rarely reported in both the domestic and international literature. PATIENT CONCERNS: A 47-year-old male, asymptomatic except for a palpable right neck nodule detected during routine follow-up, was diagnosed with RT secondary to papillary thyroid carcinoma. To our knowledge, this is the inaugural case of its nature ever documented, providing valuable insights into the relationship between malignant tumors and IgG4-RDs. DIAGNOSES: Histopathological examination revealed fibrous tissue hyperplasia, atrophic thyroid follicles, extensive infiltration of lymphocytes and plasma cells, and perivascular inflammation. The pathological diagnosis was consistent with RT.
interventionsThe patient underwent thyroidectomy and neck lymph node dissection. OUTCOMES: The patient recovered uneventfully, takes levothyroxine daily to suppress thyroid-stimulating hormone, and undergoes a thyroid ultrasound and thyroid function test every 6 months. LESSONS: RT can mimic malignancy on ultrasound (e.g., thyroid imaging reporting and data system 5 features). Greater awareness and integrated clinicopathologic evaluation may prevent unnecessary surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.